Executive VP R and D and Chief Scientific Officer @ (January 2010 - January 2013)
Chief Operating Officer, CSO, Board Member @ Hydra Biosciences (January 2003 - January 2010)
VP and Therapeutic Area Head @ Wyeth (Pfizer) (January 1999 - January 2003)
VP Preclinical R and D @ Genetics Institute (Wyeth Research) (January 1993 - January 1999)
Glenn Larsen Education
Harvard Business School
Stony Brook University
Doctor Of Philosophy (Philosophy)
Glenn Larsen Skills
Biology
Biopharmaceuticals
Biotechnology
Clinical Development
Clinical Trials
Drug Development
Drug Discovery
Immunology
Inflammation
Lifesciences
Oncology
Pain Management
Pharmaceutical Industry
Pharmacology
R&D
Science
Technology Transfer
Wealth Management
Customer Service
Management
Marketing Strategy
Personal Financial Planning
Public Speaking
Business Development
Glenn Larsen Summary
Glenn Larsen, based in Cambridge, MA, US, is currently a Co-founder, President and CEO at Aquinnah Pharmaceuticals. Glenn Larsen brings experience from previous roles at Anika Therapeutics (ANIK), 180 Therapeutics LP, SpringLeaf Therapeutics and Hydra Biosciences. Glenn Larsen holds a Harvard Business School. With a robust skill set that includes Biology, Biopharmaceuticals, Biotechnology, Clinical Development, Clinical Trials and more. Glenn Larsen has 2 emails and 5 mobile phone numbers on RocketReach.
Looking for a different Glenn Larsen?
Find contact details for 700 million professionals.